DOA
NARI

D'Orazio & Associates’s Inari Medical, Inc. Common Stock NARI Stock Holding History

D'Orazio & Associates’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-300
Closed -$21K – 378
2020
Q3 		$21K Buy
+300
New +$19.3K 0.01% 195

Other funds holding NARI

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

D'Orazio & Associates's NARI Position: Q4 2020 in Review

D'Orazio & Associates sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2020, closing a stake of 300 shares — an estimated $21K sold.

D'Orazio & Associates first reported a position in NARI in Q3 2020 and held it in 1 quarter. The position peaked at $21K in Q3 2020. 152 funds tracked by Wall St. Rank hold NARI as of Q4 2020.

  • D'Orazio & Associates reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • D'Orazio & Associates sold 300 Inari Medical, Inc. Common Stock shares in Q4 2020, an estimated $21K.
  • D'Orazio & Associates first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • D'Orazio & Associates's Inari Medical, Inc. Common Stock position peaked at $21K in Q3 2020.
  • 152 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2020.

Based on D'Orazio & Associates's 13F filing for Q4 2020, filed 5 Feb 2021.